Priming and release of cytokine IL-1β in microglial cells from the retina

Keith E Campagno1, Wennan Lu1, Puttipong Sripinun2

  • 1Department of Basic and Translational Science, University of Pennsylvania, Philadelphia, PA, 19104, United States.

Experimental Eye Research
|January 23, 2025
PubMed

Insights

This study shows that retinal microglial cells directly release the cytokine IL-1β upon stimulation by extracellular ATP via the P2X7 receptor (P2X7R). This finding implicates microglial cells in retinal degeneration diseases.

Area of Science:

  • Neuroscience
  • Immunology
  • Ophthalmology

Background:

  • The P2X7 receptor (P2X7R) is linked to retinal degeneration, but its role in retinal microglia releasing IL-1β is unclear.
  • Evidence for IL-1β release from retinal microglia is indirect, necessitating direct investigation.

Purpose of the Study:

  • To determine if ATP directly induces IL-1β release from retinal microglial cells.
  • To investigate if P2X7R stimulation primes IL-1β expression at mRNA and protein levels in retinal microglia.

Main Methods:

  • Isolated mouse and rat retinal microglia were used to assess P2X7R expression and function.
  • Retinal wholemounts from Cx3CR1+/GFP mice were utilized to visualize IL-1β and microglial responses in situ.
  • ATP, P2X7R antagonist A839977, and agonist BzATP were employed to study IL-1β release and priming.

Main Results:

  • Over 90% of isolated retinal microglia expressed P2X7R, with stimulation causing Ca2+ influx.
  • ATP induced a dose-dependent release of IL-1β from primed microglia, blocked by A839977 and mimicked by BzATP.
  • P2X7R stimulation primed Il1b mRNA and increased IL-1β immunostaining in retinal wholemounts, with some colocalization with microglia, particularly in the outer retina.

Conclusions:

  • Microglial cells are a primary source of IL-1β release in response to elevated extracellular ATP in retinal damage.
  • P2X7R signaling in retinal microglia plays a direct role in IL-1β release and priming.
  • The outer retina may experience greater microglial participation in IL-1β-mediated inflammatory responses.